Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3031% above fair value
$2.65−0.16 (-5.69%)
Close on Nov 16, 2026Market cap $111.63MP/E –Yield –
Apyx Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Apyx Medical's revenue for the twelve months ending Sep 30, 2026 was $59.57M, up 24.4% year over year. For fiscal 2025 it was $52.84M, up 9.9% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $52.84M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.84M | +9.9% |
| FY2024 | Dec 31, 2024 | $48.10M | -8.1% |
| FY2023 | Dec 31, 2023 | $52.35M | +17.6% |
| FY2022 | Dec 31, 2022 | $44.51M | -8.3% |
| FY2021 | Dec 31, 2021 | $48.52M | +75.1% |
| FY2020 | Dec 31, 2020 | $27.71M | -1.9% |
| FY2019 | Dec 31, 2019 | $28.24M | +70.0% |
| FY2018 | Dec 31, 2018 | $16.61M | +62.3% |
| FY2017 | Dec 31, 2017 | $10.23M | +16.0% |
| FY2016 | Dec 31, 2016 | $8.82M | -70.1% |
| FY2015 | Dec 31, 2015 | $29.52M | +6.6% |
| FY2014 | Dec 31, 2014 | $27.68M | +17.0% |
| FY2013 | Dec 31, 2013 | $23.66M | -14.5% |
| FY2012 | Dec 31, 2012 | $27.67M | +8.9% |
| FY2011 | Dec 31, 2011 | $25.41M | +4.9% |
| FY2010 | Dec 31, 2010 | $24.23M | -10.1% |
| FY2009 | Dec 31, 2009 | $26.95M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $14.03M | +9.0% |
| Q2 FY2026 | Jun 30, 2026 | $13.88M | +22.1% |
| Q1 FY2026 | Mar 31, 2026 | $12.49M | +32.4% |
| Q4 FY2025 | Dec 31, 2025 | $19.16M | +34.7% |
| Q3 FY2025 | Sep 30, 2025 | $12.88M | +12.1% |
| Q2 FY2025 | Jun 30, 2025 | $11.37M | -6.4% |
| Q1 FY2025 | Mar 31, 2025 | $9.43M | -7.9% |
| Q4 FY2024 | Dec 31, 2024 | $14.22M | -3.0% |
| Q3 FY2024 | Sep 30, 2024 | $11.49M | -4.1% |
| Q2 FY2024 | Jun 30, 2024 | $12.15M | -10.5% |
| Q1 FY2024 | Mar 31, 2024 | $10.24M | -15.6% |
| Q4 FY2023 | Dec 31, 2023 | $14.66M | +16.3% |
| Q3 FY2023 | Sep 30, 2023 | $11.98M | +31.4% |
| Q2 FY2023 | Jun 30, 2023 | $13.57M | +31.8% |
| Q1 FY2023 | Mar 31, 2023 | $12.14M | -2.8% |
| Q4 FY2022 | Dec 31, 2022 | $12.61M | -25.0% |
| Q3 FY2022 | Sep 30, 2022 | $9.11M | -23.0% |
| Q2 FY2022 | Jun 30, 2022 | $10.29M | -8.3% |
| Q1 FY2022 | Mar 31, 2022 | $12.49M | +44.6% |
| Q4 FY2021 | Dec 31, 2021 | $16.82M | +46.8% |
| Q3 FY2021 | Sep 30, 2021 | $11.83M | +70.1% |
| Q2 FY2021 | Jun 30, 2021 | $11.22M | +161.3% |
| Q1 FY2021 | Mar 31, 2021 | $8.64M | +72.9% |
| Q4 FY2020 | Dec 31, 2020 | $11.46M | +36.8% |
| Q3 FY2020 | Sep 30, 2020 | $6.95M | -8.2% |
| Q2 FY2020 | Jun 30, 2020 | $4.30M | -35.4% |
| Q1 FY2020 | Mar 31, 2020 | $5.00M | -11.2% |
| Q4 FY2019 | Dec 31, 2019 | $8.38M | +43.4% |
| Q3 FY2019 | Sep 30, 2019 | $7.58M | +106.3% |
| Q2 FY2019 | Jun 30, 2019 | $6.65M | +80.1% |
| Q1 FY2019 | Mar 31, 2019 | $5.63M | +65.7% |
| Q4 FY2018 | Dec 31, 2018 | $5.85M | +59.8% |
| Q3 FY2018 | Sep 30, 2018 | $3.67M | +38.5% |
| Q2 FY2018 | Jun 30, 2018 | $3.69M | +59.7% |
| Q1 FY2018 | Mar 31, 2018 | $3.40M | +110.5% |
| Q4 FY2017 | Dec 31, 2017 | $3.66M | -61.5% |
| Q3 FY2017 | Sep 30, 2017 | $2.65M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.49M | – |
See a number that looks wrong?